Goldman Sachs’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$278K Sell
4,891
-9,395
-66% -$535K ﹤0.01% 4557
2025
Q1
$801K Sell
14,286
-495
-3% -$27.7K ﹤0.01% 3957
2024
Q4
$909K Buy
14,781
+7,778
+111% +$478K ﹤0.01% 3969
2024
Q3
$469K Buy
7,003
+3,898
+126% +$261K ﹤0.01% 4142
2024
Q2
$207K Sell
3,105
-4,595
-60% -$307K ﹤0.01% 4352
2024
Q1
$548K Sell
7,700
-26,812
-78% -$1.91M ﹤0.01% 3951
2023
Q4
$2.91M Sell
34,512
-6,444
-16% -$543K ﹤0.01% 2966
2023
Q3
$3.52M Buy
40,956
+100
+0.2% +$8.6K ﹤0.01% 2730
2023
Q2
$3.81M Sell
40,856
-2,604
-6% -$243K ﹤0.01% 2763
2023
Q1
$4.12M Buy
43,460
+2,465
+6% +$234K ﹤0.01% 2676
2022
Q4
$4.12M Buy
40,995
+5
+0% +$503 ﹤0.01% 2766
2022
Q3
$3.5M Buy
40,990
+10,232
+33% +$873K ﹤0.01% 2934
2022
Q2
$2.64M Buy
30,758
+1,457
+5% +$125K ﹤0.01% 3226
2022
Q1
$2.63M Sell
29,301
-4,019
-12% -$361K ﹤0.01% 3348
2021
Q4
$3.33M Sell
33,320
-1,043
-3% -$104K ﹤0.01% 3115
2021
Q3
$3.19M Hold
34,363
﹤0.01% 3125
2021
Q2
$2.92M Buy
34,363
+943
+3% +$80.2K ﹤0.01% 3205
2021
Q1
$2.89M Buy
33,420
+10,427
+45% +$903K ﹤0.01% 3065
2020
Q4
$1.94M Buy
22,993
+6,025
+36% +$508K ﹤0.01% 3092
2020
Q3
$1.36M Buy
16,968
+14,489
+584% +$1.16M ﹤0.01% 3133
2020
Q2
$220K Sell
2,479
-21
-0.8% -$1.86K ﹤0.01% 3946
2020
Q1
$235K Sell
2,500
-1,654
-40% -$155K ﹤0.01% 3872
2019
Q4
$448K Buy
4,154
+1,904
+85% +$205K ﹤0.01% 3701
2019
Q3
$216K Buy
2,250
+18
+0.8% +$1.73K ﹤0.01% 3893
2019
Q2
$214K Buy
+2,232
New +$214K ﹤0.01% 3847
2018
Q4
Sell
-2,548
Closed -$240K 4248
2018
Q3
$240K Buy
2,548
+117
+5% +$11K ﹤0.01% 3746
2018
Q2
$268K Buy
+2,431
New +$268K ﹤0.01% 3770
2017
Q2
Sell
-4,377
Closed -$273K 4530
2017
Q1
$273K Buy
+4,377
New +$273K ﹤0.01% 3821